Department of Defense PTSD Adaptive Platform Trial - Intervention A - Fluoxetine

NCT05948553 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Post Traumatic Stress Disorder

Interventions

DRUG: Intervention A Fluoxetine Hydrochloride (HCl)
DRUG: Intervention A Placebo

Sponsor

Global Coalition for Adaptive Research

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]